Alexandra Wood (Canada) Inc. 13D and 13G filings for Chromocell Therapeutics Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-01-15 5:27 pm Purchase |
2024-12-13 | 13G | Chromocell Therapeutics Corporation CHRO |
Alexandra Wood (Canada) Inc. | 574,187 9.530% |
574,187 (New Position) |
Filing |